Can DKI-MRI predict recurrence and invasion of peritumoral zone of hepatocellular carcinoma after transcatheter arterial chemoembolization?

Table 1 Summary of clinical data of patients in true and pseudo-progressing groups

Characteristic	All cases (n = 82)		True group (n = 48)	Pseudo-group (n = 34)	P value
Age range (yr)	55 ± 12		50 ± 16	53 ± 14	0.745
Male/female (n)	46/30		26/18	20/12	0.402
AFP (ng/mL) (+/-)	49/33		47/1	2/32	0.001
	Tumor-related characteristics
Tumor size (cm)	4.0 ± 1.8		4.2 ± 1.6	2.7 ± 1.3	0.142
Enhancement (+/-)	50/32		46/2	4/30	0.006
DSA (+/-)	42/27		42/2	0/25	< 0.010
Resection (+/-)	10		9	1	-
TACE times (single/repeated)	26/56		4/44	22/12	< 0.011
Follow-up for > 6 mo (+/-)	39/33		39/0	0/33	< 0.001

AFP: Alpha-fetoprotein; DSA: Digital subtraction angiography; TACE: Transcatheter arterial chemoembolization.